SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
ArQule, Inc./Daiichi Sankyo, Inc. Report Positive Phase 2 Study Results for Tivantinib in Previously Treated Hepatocellular Carcinoma Presented at American Society of Clinical Oncology